BioSpace News Archive

Immunome, Inc., a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced that Purnanand Sarma, Ph.D., Immunome’s President and CEO, will present at the Stifel Healthcare Conference on Monday, November 15, 2021 at 8:00 a.m. ET.

Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.

Fulgent Genetics, Inc., a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced financial results for its third quarter ended September 30, 2021.

Anocca AB, a leader in unlocking the potential of T cell immunotherapy to deliver transformative T cell receptor engineered T cell therapeutics (TCR-T), today announced it has appointed a new Head of Clinical Development, Sandra Bevan MSc.

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring systems for people with diabetes, reported financial results for the quarter ended September 30, 2021.

Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the third quarter ended September 30, 2021.

Mirati Therapeutics, Inc. a clinical-stage oncology company, announced that it intends to offer and sell in an underwritten public offering $500 million of shares of its common stock.

Arcus Biosciences, Inc., an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, announced that the Compensation Committee of the Company’s Board of Directors granted one new employee options to purchase a total of 28,000 shares of the Company’s common stock at an exercise price per share of $34.74, which was the closing price on November 8, 2021.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended September 30, 2021, and raised its full-year guidance for 2021.

Streamline Health Solutions, Inc. (Nasdaq: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and improve financial performance, has been invited to participate in the 12th Annual Craig-Hallum Alpha Select Conference, which is being held virtually on Tuesday, November 16, 2021.